SFC

CARDIOLOGIE PEDIATRIQUE

  • Outcomes following prenatal diagnosis of isolated persistent left superior vena cava [SCIENCE DIRECT]

CARDIO-ONCOLOGIE

  • Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies [ACADEMIC]
  • Cardiac Involvement of Metastatic Clear Cell Sarcoma: A Multimodality Imaging Report [OVIDSP]

CORONAIRES ET INTERVENTIONNEL

  • Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial [JAMA NETWORK]
  • Differential Impact of Coronary Revascularization on Long-Term Clinical Outcome According to Coronary Flow Characteristics: Analysis of the International ILIAS Registry [AHA JOURNALS]
  • Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study [JACC]
  • International Hand Function Study Following Distal Radial Access: The RATATOUILLE Study [JACC]
  • Predicted and Observed Mortality at 10-Years in Patients With Bifurcation Lesions in the SYNTAX Trial [JACC]
  • Six-Month Outcomes of the TricValve® System in Patients with Tricuspid Regurgitation: TRICUS EURO Study [JACC]
  • Distal Versus Conventional Radial Access for Coronary Angiography and Intervention (DISCO RADIAL) [JACC]
  • Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes [JACC]

HTA

  • Kidney Denervation Results in Lasting Blood Pressure Control [JAMA NETWORK]

IMAGERIE CARDIOVASCULAIRE

  • Lung Ultrasound During Exercise Echocardiography: Necessity or Whim? [OVIDSP]
  • Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation [OVIDSP]
  • Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions [JACC]

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

  • Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial [AHA JOURNALS]
  • Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF [AHA JOURNALS]
  • Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction [AHA JOURNALS]
  • Electrical management of heart failure: from pathophysiology to treatment [ACADEMIC]
  • Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality [ACADEMIC]

RISQUE CARDIOVASCULAIRE

  • Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis [ACADEMIC]

RYTHMOLOGIE

  • Leadless atrioventricular synchronous pacing in an outpatient setting: Early lessons learned on factors affecting atrioventricular synchrony [HEART RHYTHM JOURNAL]
  • Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy [HEART RHYTHM JOURNAL]
  • The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy [ACADEMIC]

USIC

  • Disruption of Circadian Rhythms by Shift Work Exacerbates Reperfusion Injury in Myocardial Infarction [JACC]

VALVULOPATHIES

  • Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions [JACC]
  • Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic StenosisA Randomized Clinical Trial [JAMA NETWORK]

COVID

  • Cardiac Complications More Common After COVID-19 Than Vaccination [JAMA NETWORK]
  • Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine [NEJM]
  • BNT162b2 Protection against the Omicron Variant in Children and Adolescents [NEJM]
  • Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants [NEJM]

LA FRANCE A L’HONNEUR

  • The European Cardiac Arrhythmia Genetics (ECGen) Focus Group [ACADEMIC]

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !